Pulse Biosciences, Inc.
NASDAQ: PLSE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Paul Arthur LaViolette
- Employees
- 75
- Headquarters
- Miami, United States
- IPO year
- 2016
- Market cap
- $1.8B
- Website
- https://www.pulsebiosciences.com
Loading PLSE…
Loading profile data…Frequently asked questions about PLSE
What does Pulse Biosciences, Inc. (PLSE) do?
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulse...
Where does PLSE trade?
Pulse Biosciences, Inc. (PLSE) trades on the NASDAQ Capital Market.
What sector is PLSE in?
Pulse Biosciences, Inc. (PLSE) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Pulse Biosciences, Inc.?
Paul Arthur LaViolette is the chief executive officer of Pulse Biosciences, Inc. (PLSE).
Where is Pulse Biosciences, Inc. headquartered?
Pulse Biosciences, Inc. is headquartered in United States.
Does PLSE pay a dividend?
Pulse Biosciences, Inc. (PLSE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PLSE go public?
Pulse Biosciences, Inc. (PLSE) completed its initial public offering in 2016.